海南發展(002163.SZ)擬向海南控股發行股份募資不超20億元 發行價13.58元/股
格隆匯9月18日丨海南發展(002163.SZ)發佈2020年度非公開發行A股股票預案,本次非公開發行的A股股票為境內上市人民幣普通股(A股),每股面值人民幣1.00元。
發行對象為海南省發展控股有限公司,擬認購股份數量為1.47億元,發行價格為13.58元/股。
本次非公開發行股票募集資金總額不超過20億元(含本數),扣除發行費用後擬用於收購國善實業100%股權及海口市大英山新城市中心區D01地塊辦公商業綜合體項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.